监事、
市场风险······························ 121 六、本站导航向公开引进的战略投资者增资······················47 四、监事、公开引进战略投资者的评选办法·····················65 第八章 董事、实施募集资金运用项目的可行、本次增资募集资金投向························ 110 二、岳兴长石化股份有限公司重庆康卫生物科技有限公司公开引进战略投资者说明书岳兴长石化股份有限公司重庆康卫生物科技有限公司公开引进战略投资者说明书查看PDF公告岳兴长石化股份有限公司重庆康卫生物科技有限公司公开引进战略投资者说明书 1 重庆康卫生物科技有限公司 公开引进战略投资者说明书 二〇〇九年八月重庆康卫生物科技有限公司 公开引进战略投资者说明书 2 目录 第一章 释义···························· 4 第二章 概览···························· 6 一、
监事、监事、公司本次增资实际募集资金金额·····················51 六、公司实施励方案后增加的注册资本···················44 三、公司税项·······························89 第十章 我国幽门螺杆疫苗行业市场况·············· 90 一、公开引进战略投资者的确定·······················13 第三章 公司历史沿革、
实施本次增资方案的附加条件······················49 五、 公司理结构风险·························· 120 二、募集资金运用项目财务评价······················ 111 第十三章 风险因素························ 120 一、公司研发况·····························25 五、我国幽门螺杆疫苗市场前景······················94 第十一章 公司未来发展规划及产品产业化实施方案·········· 103 一、公司的事项····························89 四、公司人员况·····························24 三、公司经营况·····························24 四、公司研发的幽门螺杆疫苗优势分析···················29 五、公开引进战略投资者的程序·······················64 三、必要及紧迫············ 110 三、本次增资方案简介··························· 7 四、 会计估计和会计报表编制
方法··········69 二、本次增资前持有公司5%以上出资法人股东况介绍·············22 &en
sp;三、公司历史沿革·····························14 二、
产业化进展滞后风险························· 120 三、产品产业化实施方案························· 105 三、公司研发的幽门螺杆疫苗况·····················33 六、主要高管人员简历···························66 三、主要股东况················ 14 &e
nsp;一、幽门螺杆感染的流行学况·····················90 二、实施本次增资方案的前提条件······················53 第七章 公开引进战略投资者的条件、幽门螺杆疫苗产业化初步时间安排·················· 108 第十二章 募集资金运用及项目财务评价··············· 110 一、 程序及评选办法········· 54 一、高级管理人员持有公司出资的况··············68 第九章 公司财务会计信息····················· 69 一、公司的新证书····························29 四、 本次增资动因····························· 6 三、公司目前选用的会计政策、技术风险······························ 121 五、重庆帅博 本次增资的定价及依据·························51 七、高级管理人员基本况·················66 二、本次增资的定价及依据·························12 五、产业化实施风险··························· 120 四、自营进出口权高级管理人员················· 66 一、
公开引进战略投资者的条件·······················54 二、与公司产品相关的专利况·······················37 第六章 公司本次增资方案····················· 39 一、公司未来发展战略·························· 103 二、专家评审小组的人员及构成·······················65重庆康卫生物科技有限公司 公开引进战略投资者说明书 3 四、董事、公司基本况简介···························24 二、高级管理人员的定协议安排················67 四、管理风险······························ 122双碑注册进出口公司 股东股权冻结或质押况························23 第四章 公司基本况······················· 24  一、公司实施本次增资的前提条件······················13 六、公司经审计的会计报表·························85 三、公司知识产权·····························27 三、 公司主要资产·····························27 二、现任董
事、重庆康卫概况····························· 6 二、董事、公司原有股东增资···························39 二、
